Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China-Reference-Cited by-同舟云学术

Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China

Published:2023-10-28 Issue:6 Volume:29 Page:692-698
ISSN:1355-0284
Container-title:Journal of NeuroVirology
language:en
Short-container-title:J. Neurovirol.

Author:

Fan Siyuan,Liu Mange,Bai Lin,Chen Sixian,Hou Bo,Lin Nan,Yuan Jing,Mao Chenhui,Niu Jingwen,Ren Haitao,Zhao Yanhuan,Zhang Zaiqiang,Zhu Yicheng,Peng Bin,Guan Hongzhi

Funder

National High Level Hospital Clinical Research Funding

Special Fund for Scientific Innovation Strategy-Construction of High-level Academy of Agriculture Science

Publisher

Springer Science and Business Media LLC

Subject

Virology,Cellular and Molecular Neuroscience,Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s13365-023-01180-w.pdf

Reference33 articles.

1. Beck ES, Cortese I (2020) Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy. Curr Opin Virol 40:19–27

2. Bennett KM, Fernandes PM (2020) Novel treatments for progressive multifocal leukoencephalopathy. Br J Hosp Med 81:1–9

3. Bernard-Valnet R, Koralnik IJ, Du Pasquier R (2021) Advances in treatment of progressive multifocal leukoencephalopathy. Ann Neurol 90:865–873

4. Beudel M, Rövekamp F, van de Beek D, Brouwer M (2021) Single-dose pembrolizumab treatment for progressive multifocal leukoencephalopathy. Neurol Neuroimmunol Neuroinflamm 8:e1021

5. Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, Sühs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G (2023) Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors. Ann Neurol 93:257–270

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progressive multifocal leukoencephalopathy in sarcoidosis successfully treated with pembrolizumab;Journal of NeuroVirology;2024-08-18